Diagnostic
Grafton Optical: Moptim DEA Dry Eye Analyser
The Moptim DEA Dry Eye Analyser is available in the UK from Grafton Optical and is said to quickly perform a comprehensive examination for complete dry eye diagnosis and management. As one of the smallest dry eye diagnostic devices on the market, the device’s compact design allows easy integration into a variety of clinical environments. It can be operated as a stand-alone device, slit lamp mounted or handheld. Using the included adaptors, Grafton says the DEA can be attached to the majority of slit lamps, without affecting their use.
The DEA is said to provide complete dry eye diagnosis testing, as recommended by DEWS II. The built-in DEQ-5 questionnaire can be used in combination with objective findings to aid in diagnosis, and the Efron International Grading Scale helps to assess the severity of dry eye disease present.
Mainline Instruments: Tomey MR-6000
The Tomey MR-6000 multifunction unit is described as a time-saving and space-saving device on the basis that it offers six functions in one device, saving the need for separate machines. Distributor Mainline says it offers accurate measurement values for refraction and keratometry due to an improved measurement principle. The device’s quick refraction mode is said to allow refraction values within seconds despite fixation loss, which is particularly useful for patients with nystagmus, children or uncooperative patients.
The automated IOP correction considers pachymetry values to boost reliability of IOP values while 16 mires rings examine an area of 8mm in diameter. Several map types, including fourier analysis, lead to a wide range of corneal shape displaying opportunities. Mainline says the combination of four examinations gives a detailed impression of the health of the patient’s ocular surface and allows for the user to observe the blinking frequency, tear meniscus height, hyperemia and meibomian glands by using only one medical device.
Positive Impact: ScoutPro
ScoutPro from TruKera, formerly TearLab, is said to be the first and only osmolarity system that is portable, offering a seamless end-to-end testing method that has been designed to meet the demands of today’s busy practitioners. Distributed by Positive Impact in the UK, the ScoutPro features VeriLyte Technology, which integrates specimen collection and analysis in a single device that is practical and precise to use. Real-time results appear on the pen display within seconds, with 95% analytical accuracy compared to a laboratory standard osmometer.
The ScoutPro boasts microfluidic lab-on-a-chip technology with the innovative card design, which is said to enable tear collection from the driest patient. The ScoutPro testcards are interchangeable with the original TearLab Osmolarity System. Tony Whyatt, commercial director at Positive Impact, said: ‘Measuring osmolarity is the only definitive test to know for sure whether the patient’s symptoms are due to dry eye or not. The new ScoutPro is a fantastic upgrade that makes taking these readings easier than ever.’
Essilor: IDRA
The IDRA from Essilor is said to offer advanced high-definition testing for dry eye. The device performs a full assessment of the ocular surface via a series of quick tear film tests, including the quality of tears and analysis of the meibomian glands, to classify the type of dry eye disease. A 3D image is produced to help practitioners analyse and understand the eyelid structure. The image can also be shared with a patient to explain the cause of their discomfort and aid treatment recommendations.
Paul Cumber, Essilor’s instruments director, said: ‘The IDRA imaging system is a compact and cost-effective piece of kit, which provides strong evidence to support your choice of treatment, while helping the patient understand why that therapy is being recommended. When used alongside the TearStim Dry Eye procedure, it can provide eye care professionals with a complete diagnosis and treatment service for patients living with the most common cause of dry eye, meibomian gland dysfunction.’
BIB Ophthalmic Instruments: Medmont Meridia Professional dry eye topographer
The Medmont Meridia Professional dry eye topographer is said to extend the features of the previous Medmont E300 topographer by providing complete dry eye diagnostics, including a high end depth of focus colour anterior imaging facility, high quality fluorescein imaging, high definition meibomian gland imaging and videos for playback analysis. Distributor BIB also notes that quick and easy tear meniscus measurements can be achieved, as well as full colour limbus-to-limbus topography.
The Professional model features a choice of dry eye grading scales and reports. This evidence-based approach with collaborative views and patient reports encourages patient engagement, leading to better diagnosis, patient compliance and better patient outcomes.
Hanson Instruments: Antares+
The Antares+ from CSO is described by distributor Hanson as more than just a topographer in that it offers practitioners the ability to carry out full dry eye reports. The device can provide an Ocular Surface Disease Index (OSDI) questionnaire report, be used to take high resolution images with the 5MP camera, of both the limbal and conjunctival hyperaemia. Additionally, it can provide meibomian gland analysis, tear meniscus analysis, non-invasive break-up time analysis, and tear film analysis. The Antares+ dry eye report can then be used as a baseline and all future reports can be compared to measure any treatment completed.
Treatment
Lumenis: OptiLight
Lumenis says its OptiLight light therapy device is the first and only machine of its type to be FDA approved for dry eye management. OptiLight’s patented OPT technology is said to provide precise and controlled treatment. OptiLight aims to break the dry eye vicious cycle of inflammation by offering a multi-factorial treatment to a multi-factorial disease. It is designed with every element thoughtfully tailored to fit the needs of dry eye patients and eye care professionals.
Lumenis says there are over 40 clinical studies that support the effectiveness and safety of OptiLight. Some of the benefits include a 1.5x increase in tear break-up time, 6.3x more expressible glands, and a 2.5x reduction in pro-inflammatory mediators. Each OptiLight session takes about 15 minutes to complete, so it can easily be integrated into one’s practice with a seamless workflow. With just four easy-to-perform sessions and embedded clinical settings, OptiLight is said to help elevate clinical effectiveness, practice efficiency and business growth.
Positive Impact: NuLids
NuLids is an electronic eyelid hygiene device from Positive Impact for the management of dry eye disease, meibomian gland dysfunction and blepharitis. The device is aimed at independents for use in the practice or by the patient at home. NuLids is said to be quick and simple to use and produces little or no aerosol spray. An eye cleaning foam is applied over the closed eyelid and NuLids is then used to gently massage the eyelid, resulting in lid exfoliation and stimulating meibomian gland expression.
The device’s rotating disposable silicone soft tip is timed by the device to aid compliance. The treatment usually takes just one minute per day, with NuLids cleaning bacteria and desiccated skin from the eyelid margin, de-capping and opening the meibomian glands.
‘NuLids offers massage and cleaning in one go, and is clinically proven,’ says Positive Impact’s managing director, Nick Atkins.
Hanson Instruments: Eye-light
According to distributor Hanson, Eye-light features technologies that enable practitioners to successfully treat their patients’ dry eye disease and meibomian gland dysfunction. The Eye-light is said to offer non-invasive treatment of most ocular surface conditions. It is built with three elements: the device itself, from which the treatments are controlled, and the two terminals; one for OPE Intense Pulsed Light (IPL) and one for LM LLLT. LM LLLT is a patented photo biomodulation technology that is said to enable practitioners to optimally treat meibomian gland dusfunction and many other ocular surface pathologies that would not be possible by using an IPL alone. By increasing and stabilising patients’ lacrimal film, LM LLLT aims to give practitioners the ability to manage their patients’ dry eye disease in the long term.
Essilor: TearStim
TearStim, available from Essilor, is said to provide a long-lasting solution for dry eye syndrome, ensuring the meibomian glands are functioning properly. The procedure emits painless light pulses below the eye in the region of the parasympathetic nervous system, and by stimulating the nerve, neurotransmitters are released that encourage the secretion of the meibomian glands and contribute to restoring their normal activity. In addition, the quality of the gland secretion is improved, and the lipid layer of the tear film is stabilised.
Paul Cumber, instruments director at Essilor, says: ‘The effectiveness of Intense Regulated Pulsed Light treatments, such as TearStim, can be enhanced further by using the Activa Home Eye Mask, which uses heat and massage to increase meibomian gland output, so eyes stay lubricated and symptom-free for longer.’